Test Duration
5 Minutes
------ To ------10 Minutes
Test Cost
₹ 2,199
------ To ------₹ 3,000
For those expecting a bundle of joy, the triple marker test adds an extra layer of care and peace of mind to their pregnancy journey! The test is a crucial prenatal screening tool to assess certain abnormalities and disorders in developing foetuses.
A triple marker test can help expectant parents receive valuable insights into their baby’s health without any discomfort. It provides the information and assurance individuals need to cherish every moment of this beautiful journey into parenthood!
The following blog discusses triple market test price, procedure, results, and more. Read on to find out.
Alternative Name |
Triple Screen Test |
Prerequisites |
No special preparations are required |
Test Done By |
Gynaecologist |
Parameters Covered |
Alpha-Fetoprotein (AFP), Human Chorionic Gonadotropin (hCG), and estriol |
Download our App today to plan your surgery seamlessly and stress-free!
The triple marker test, or the triple screen test, is a prenatal blood test. But the question remains, what is the appropriate triple marker test time? Thetest is performed between 15 and 20 weeks of gestation. It involves analysing three specific substances in the mother’s blood:
Alpha-Fetoprotein (AFP): This protein is produced by the foetal liver during foetal development. Some of this protein passes through the placenta into the mother’s bloodstream. Abnormal levels of AFP may indicate a higher risk of genetic defects.
Human Chorionic Gonadotropin (hCG): The placenta produces this hormone during pregnancy. The hCG levels help detect chromosomal abnormalities.
Estriol: It is an oestrogen hormone produced by both the foetus and the placenta. Low levels of estriol can indicate abnormal pregnancy risk.
The triple marker blood test aims to assess the risk of genetic abnormalities in the foetus. The test helps in the prenatal screening of the following conditions
Down Syndrome (Trisomy 21): A condition in which the baby is born with an extra copy of chromosome 21.
Edward’s Syndrome (Trisomy 18): Babies with this condition have three copies of chromosome 18 at birth instead of two.
Neural Tube Defects: These defects occur due to the failure of the neural tubes to close properly. The two most common neural tube defects include:
Spina Bifida: Incomplete development of the foetus’s spine
Anencephaly: A severe condition in which a child is born without certain portions of their skull or brain
Multiple Births: Triple marker test in pregnancy can also help determine if the mother is expecting multiple babies.
The triple marker test estimates the likelihood of certain conditions in the baby. However, one must note that it is not a diagnostic test. It only offers a risk assessment and may require additional tests for diagnosis.
The triple marker test offers several benefits for expectant parents during pregnancy. The test is especially beneficial for women with the following:
A family history of genetic conditions
Age above 35 years
Diabetes (women who take insulin)
Radiation exposure
Severe viral infection during pregnancy
Used harmful medications or drugs during pregnancy
Some of the benefits of the triple marker test include the following:
Safe Procedure: The triple marker test is a non-invasive blood draw test. It poses minimal risk to both the mother and the baby, making it a safe option for prenatal screening.
Screening of Potential Abnormalities: The test can identify the risk of disorders like Down syndrome early in pregnancy. This helps the parents make informed decisions about their pregnancy and the baby’s future.
Planning and Preparation: When potential health issues are detected, the test gives parents sufficient time to plan and prepare for the birth of a child with special needs.
Avoiding Unnecessary Interventions: For parents with low-risk results, the test can help avoid unnecessary invasive procedures, which carry a slightly higher risk of complications.
Monitoring Multiple Pregnancies: It helps determine if the mother carries multiple babies (twins, triplets, etc.). This helps the parents prepare for birth and assess the health of each foetus individually.
Preparing for a triple marker test is relatively simple. It usually does not require any special measures. However, the following are some general guidelines to consider before the test:
Consult a Healthcare Professional: The expectant parents should consult their healthcare provider before undergoing a triple marker test. They will give the required information about the test and address the patient’s concerns.
Book the Test: The most suitable triple marker test weeks are the 15th to 20th weeks of pregnancy. Therefore, individuals must schedule the test during this time.
Diet: Triple marker is a normal blood test that does not require fasting.
Women should eat a healthy meal with proteins and whole-grain carbohydrates to prevent light-headedness.
They should drink plenty of water before the test to stay hydrated.
They must avoid drinking alcohol or caffeine for 24 hours before the test.
A triple marker test involves a simple blood draw from the pregnant woman. It is similar to any other blood test. The entire blood draw process for the triple marker test is usually quick and should not take more than a few minutes. Here is the step-by-step procedure for the test:
Positioning: The patient will be asked to sit on a chair or lie on the examination table.
Finding the Vein: She will be asked to expose one arm. The technician will place a tourniquet (a tight elastic band) around her limb. This helps make the vein below the area swell with blood and makes it easier to find.
Cleaning the Site: The technician will clean the area over the vein with an antiseptic and antibacterial wipe to disinfect the skin and reduce the risk of infection.
Inserting the Needle: Once the vein is visible and cleaned, the technician will gently insert a thin needle into the vein to draw the blood.
Collecting Blood: The woman’s blood will be drawn from the vein and collected into a vial or syringe attached to the needle.
Removing the Needle: Once enough blood has been collected, the technician will remove the needle from the arm. They will apply light pressure on the site and place a cotton ball or sterile gauze over the puncture area. A bandage or adhesive strip will secure the site and stop any bleeding.
The patient’s blood sample will be sent to a lab for analysis.
Women generally does not require any specific care after undergoing the triple marker test. However, here are some general guidelines to follow that help enhance how they feel afterwards:
Wound Care: Individuals should not remove the bandage for at least four to six hours after the procedure.
Exercise: In most cases, women can resume their normal activities after the test. However, they must refrain from strenuous activities that may cause bleeding from the site.
Diet: Women should eat iron-rich foods after a blood draw to regain blood supply.
Ice Pack: Apply a cloth-covered ice pack on the hands or arms for soreness or bruising at the puncture site.
The triple marker test report is usually available two to four days after the test. It helps determine the mother’s risk of carrying a baby with a chromosomal abnormality or genetic disorder. However, the test is known to have a high possibility of false-positive results. Several other factors may also affect the test results, such as:
The mother’s age, weight, and ethnicity
Diabetic mother
Multiple foetus
The test results can be positive or negative. Triple marker test negative results mean that the levels of the three markers fall within the expected range for a pregnancy of that gestational age. On the other hand, the results are positive when one or more markers are outside the expected range for the given gestational age.
Triple marker test normal values suggest a lower likelihood of certain baby chromosomal abnormalities and genetic disorders. Normal values are as follows:
AFP: 1.38 to 187 IU/ml
hCG: 1.06 to 315 ng/ml
Estriol: 0.25 to 28.5 nmol/l
Triple marker test positive results do not necessarily mean a problem, but they may increase the likelihood of certain conditions in the baby.
Alpha-Fetoprotein: The most common reason for higher AFP is inaccurate pregnancy date.
Human Chorionic Gonadotropin: High levels of hCG may indicate multiple or molar pregnancy (fluid-filled sacs develop inside the uterus).
Estriol: A sudden increase in estriol levels before the 37th week of gestation may indicate a risk of premature labour.
Lower than normal levels of these three substances also denote positive results. It may increase the risk of certain disorders.
Alpha-Fetoprotein: Lower than normal levels of AFP, along with abnormal levels of hCG and estriol, may indicate conditions like:
Down syndrome
Edward’s syndrome
Other chromosomal abnormalities
Human Chorionic Gonadotropin: hCG levels lower than normal may indicate ectopic pregnancy (implantation of the fertilised egg outside the uterus) or miscarriage.
Estriol: Low estriol levels indicate the risk of Down syndrome. The risk increases when there is a low AFP level and a high hCG level.
If the triple marker test indicates an increased risk for certain conditions, further diagnostic tests may be recommended to confirm the presence of genetic abnormalities. Tests commonly used to obtain more definitive information include:
Amniocentesis: Removes a small sample of amniotic fluid for testing
Chorionic Villus Sampling (CVS): Removes a sample of tissue from the placenta for testing
Genetic counselling is essential to the treatment plan for mothers with abnormal results. Genetic counsellors provide in-depth information about the specific conditions associated with the positive results. Furthermore, they help parents understand the available options and potential outcomes.
The triple marker test is generally considered safe with no risk to the mother or foetus. However, like any medical procedure, it has potential risks and limitations. It is essential to be aware of these factors before deciding to undergo the test:
False Positive: The triple marker test can produce false positive results, indicating an increased risk of certain conditions when the baby is healthy. This may lead to unnecessary anxiety.
False Negative: The test can also produce false negative results, suggesting a lower risk when the baby does have a condition. False-negative results may cause a false sense of security.
Further Testing: If the triple marker test shows abnormal results or increased risk, further diagnostic testing is usually required to confirm the presence of any genetic abnormalities. These invasive tests carry a slight risk of complications, including infection or miscarriage.
Psychological Impact: Waiting for the test results, especially when there is an indication of increased risk, can be emotionally challenging for expectant parents. Moreover, if the results are positive, it can cause significant stress and anxiety.
Generally, the triple marker test price ranges from ₹ 2200 to ₹ 3000. However, several factors can influence the triple marker test cost in India. These factors can vary from one healthcare facility to another and may include:
City or Location: The cost of a triple marker test can vary based on the location of the test. Urban areas or regions with higher healthcare costs may have higher test prices than rural or less costly regions.
Healthcare Facility: The type of chosen healthcare facility can affect the cost. Hospitals and specialised clinics may have different pricing structures than private laboratories or diagnostic centres. The cost can also vary from one diagnostic centre to another.
Laboratory Technology: Using advanced laboratory technology or specialised equipment in the testing process can affect the overall cost.
Additional Services: If additional counselling, interpretation, or consultations with genetic counsellors are included in the test package, it may affect the overall cost.
Test Name | Cost |
Triple Marker Test | ₹ 2200 to ₹ 3000 |
The triple marker test is a critical prenatal screening tool that evaluates the risk of chromosomal abnormalities and genetic disorders in a developing foetus. The test offers expectant parents important insights early in pregnancy. While the test provides useful information, it is essential to remember that it is a screening tool and not a definitive diagnosis.
HexaHealth is your trusted partner in prenatal care, offering comprehensive support and guidance throughout the triple marker test process. With a network of advanced laboratories, HexaHealth ensures accurate and timely test results. From scheduling the test to interpreting the outcomes, we will help you make informed decisions about your pregnancy.
Download our App today to plan your surgery seamlessly and stress-free!
The triple marker test is a critical prenatal screening tool that evaluates the risk of chromosomal abnormalities and genetic disorders in a developing foetus. The test offers expectant parents important insights early in pregnancy. While the test provides useful information, it is essential to remember that it is a screening tool and not a definitive diagnosis.
HexaHealth is your trusted partner in prenatal care, offering comprehensive support and guidance throughout the triple marker test process. With a network of advanced laboratories, HexaHealth ensures accurate and timely test results. From scheduling the test to interpreting the outcomes, we will help you make informed decisions about your pregnancy.
Download our App today to plan your surgery seamlessly and stress-free!
The triple marker test,a prenatal screening tool, analyses alpha-fetoprotein, human chorionic gonadotropin, and estriol levels in the mother’s blood. By measuring these levels, the test helps evaluate the risk of certain disorders and abnormalities in the foetus.
A triple marker test in pregnancy aims to assess the risk of specific chromosomal abnormalities and genetic diseases in the developing foetus. It gives expectant parents and healthcare providers crucial information for early detection and informed decision-making.
You may need the triple marker test to know the risk of chromosomal abnormalities and genetic disorders in your developing foetus during pregnancy. Women with the following are especially recommended to undergo the test:
Age above 35 years
A family history of genetic conditions
Women who take insulin for diabetes
Exposure to radiation
Severe viral infection during pregnancy
The specific markers measured in the triple marker test are:
Alpha-Fetoprotein (AFP): Produced by the foetal liver during foetal development
Human Chorionic Gonadotropin (hCG): Produced by the placenta during pregnancy
Estriol: Produced by both the foetus and the placenta
Women can expect the following during a triple marker test:
The technician places a tight elastic band around her limb to find a vein.
They clean the area over the vein with an antiseptic swab to disinfect the skin.
Next, they gently insert a thin needle into the vein to draw the blood.
The woman’s blood collects in a vial or syringe attached to the needle.
The technician removes the needle from the arm and applies light pressure on the site.
They place a cotton ball and a bandage to secure the site and stop bleeding.
Generally, no specific lifestyle changes are required before the triple marker test. However, individuals must make sure to do the following:
Drink plenty of water
Eat a healthy diet with protein and whole-grain carbohydrates
Avoid alcohol or caffeine for 24 hours before the test
The triple marker test price can vary depending on location, healthcare facility, and additional services. It typically ranges from ₹ 2200 to ₹ 3000.
The normal values for the triple marker test can vary depending on the gestational age of the pregnancy. Generally, the range of triple marker test normal values are as follows:
AFP: 1.38 to 187 IU/ml
hCG: 1.06 to 315 ng/ml
Estriol: 0.25 to 28.5 nmol/l
The normal range of human chorionic gonadotropin (hCG) in the triple marker test can vary according to the stage of the pregnancy. Doctors compare the measured hCG levels to the expected values for that specific stage of pregnancy. Generally, the normal range of hCG is 1.06 to 315 ng/ml.
The time to receive the results of the triple marker test can vary based on the healthcare facility or laboratory. Generally, the results take about two to four days.
The triple marker test report includes the measured levels of AFP, hCG, and estriol in the mother’s blood. It assesses the risk for certain chromosomal abnormalities and genetic disorders in the developing foetus.
Triple marker test results indicate the risk of genetic disorders in the developing foetus.
Normal or negative results may mean a lower likelihood of these abnormalities or disorders in the baby.
Triple marker test positive results may suggest an increased risk, necessitating further diagnostic testing for confirmation.
A triple marker test normal report is when the measured levels of AFP, hCG, and estriol fall within the expected range. This indicates a lower risk of certain chromosomal abnormalities and genetic disorders. Individuals should consult their doctor to determine if their results are normal.
Triple marker test low values may indicate an increased risk of certain chromosomal abnormalities and genetic disorders.
Low AFP levels indicate conditions like Down syndrome, Edward’s syndrome, neural tube defects, and other chromosomal abnormalities.
Lower than normal hCG levels indicate ectopic pregnancy or miscarriage.
Low estriol levels indicate a risk of Down syndrome.
High values in the triple marker test may indicate the following:
Higher AFP levels may indicate an inaccurate date of pregnancy.
High hCG levels can be due to multiple or molar pregnancy.
The most common cause of an abnormal triple screen test is an inaccurate estimation of the pregnancy date. Abnormal test results can result from an inconsistency in gestational age estimation and the actual stage of pregnancy.
Insurance coverage of the triple marker test varies depending on the insurance plan. Some insurance plans may cover the triple marker test cost. Individuals must check with their insurance provider to determine the specifics of their coverage.
The triple marker test is safe and non-invasive, with no complications to the mother or baby. However, false positive or negative results may occur, leading to unnecessary anxiety or a false sense of security. Expectant mothers may also need to undergo further invasive testing for confirmation.
No, the triple marker test cannot detect all possible birth defects. It primarily screens for certain chromosomal abnormalities and neural tube defects. It is important to remember that a triple-marker blood test is a screening tool and not a comprehensive diagnostic test.
The accuracy of the triple marker test in detecting chromosomal abnormalities varies. It can detect certain conditions with a moderate level of accuracy. However, it may also produce false positive or false negative results. According to a study by NCBI, the detection rate of the triple marker test is 67%, with a false-positive rate of 5%.
The triple marker test is typically performed between the 15th and 20th weeks of gestation, known as the second trimester. Triple marker test week is timed for accurate evaluation while providing sufficient time for further interventions if needed.
No, the triple marker test cannot determine the gender of the baby. It is a prenatal screening test that assesses the risk of certain chromosomal abnormalities and genetic disorders.
Yes, several factors can influence the levels of the markers in the mother’s blood and potentially impact the test results. These factors include:
Inaccurate gestational age estimation
Age of the mother
Her weight
Ethnicity
Multiple pregnancies
Certain medications or health conditions
No, the triple marker test cannot diagnose Down syndrome. It is a screening test that only assesses the risk of certain conditions. Further diagnostic testing, like amniocentesis or chorionic villus sampling (CVS), is required for a definitive diagnosis. These tests help diagnose Down syndrome or other chromosomal abnormalities.
No, the triple marker test is not a mandatory screening test during pregnancy. It is an optional test. Whether to undergo the test or not is a personal decision. It should be discussed with the healthcare provider based on individual circumstances.
Yes, the triple marker test can predict the risk of neural tube defects in the developing foetus. Abnormal alpha-fetoprotein levels in the test results may indicate a higher risk of neural tube defects, like spina bifida or anencephaly.
The recommended timing for undergoing the triple marker test is typically between the 15th and 20th weeks of pregnancy. This is the second trimester which allows for accurate assessment.
All the articles on HexaHealth are supported by verified medically-recognized sources such as; peer-reviewed academic research papers, research institutions, and medical journals. Our medical reviewers also check references of the articles to prioritize accuracy and relevance. Refer to our detailed editorial policy for more information.
She has extensive experience in content and regulatory writing with reputed organisations like Sun Pharmaceuticals and Innodata. Skilled in SEO and passionate about creating informative and engaging medical conten...View More